Barkhof F - Search Results

1

Fatigue in multiple sclerosis: interrelations between fatigue complaints, cerebral MRI abnormalities and neurological disability.

van der Werf SP, Jongen PJ, Lycklama à Nijeholt GJ, Barkhof F, Hommes OR, Bleijenberg G. van der Werf SP, et al. Among authors: barkhof f. J Neurol Sci. 1998 Oct 8;160(2):164-70. doi: 10.1016/s0022-510x(98)00251-2. J Neurol Sci. 1998. PMID: 9849800 Clinical Trial.

2

A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone.

Barkhof F, Frequin ST, Hommes OR, Lamers K, Scheltens P, van Geel WJ, Valk J. Barkhof F, et al. Neurology. 1992 Jan;42(1):63-7. doi: 10.1212/wnl.42.1.63. Neurology. 1992. PMID: 1370864

3

CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone.

Frequin ST, Barkhof F, Lamers KJ, Hommes OR, Borm GF. Frequin ST, et al. Among authors: barkhof f. Acta Neurol Scand. 1992 Sep;86(3):291-7. doi: 10.1111/j.1600-0404.1992.tb05088.x. Acta Neurol Scand. 1992. PMID: 1384263

4

Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.

Barkhof F, Scheltens P, Frequin ST, Nauta JJ, Tas MW, Valk J, Hommes OR. Barkhof F, et al. AJR Am J Roentgenol. 1992 Nov;159(5):1041-7. doi: 10.2214/ajr.159.5.1414773. AJR Am J Roentgenol. 1992. PMID: 1414773

5

The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis.

Frequin ST, Barkhof F, Lamers KJ, Hommes OR. Frequin ST, et al. Among authors: barkhof f. J Neuroimmunol. 1992 Oct;40(2-3):265-72. doi: 10.1016/0165-5728(92)90142-8. J Neuroimmunol. 1992. PMID: 1430156 Review.

6

Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis.

van Engelen BG, Hommes OR, Pinckers A, Cruysberg JR, Barkhof F, Rodriguez M. van Engelen BG, et al. Among authors: barkhof f. Ann Neurol. 1992 Dec;32(6):834-5. doi: 10.1002/ana.410320624. Ann Neurol. 1992. PMID: 1471879 No abstract available.

7

Meningeal Gd-DTPA enhancement in multiple sclerosis.

Barkhof F, Valk J, Hommes OR, Scheltens P. Barkhof F, et al. AJNR Am J Neuroradiol. 1992 Jan-Feb;13(1):397-400. AJNR Am J Neuroradiol. 1992. PMID: 1595484 Free PMC article. No abstract available.

8

Gadopentetate dimeglumine enhancement of multiple sclerosis lesions on long TR spin-echo images at 0.6 T.

Barkhof F, Valk J, Hommes OR, Scheltens P, Nauta JJ. Barkhof F, et al. AJNR Am J Neuroradiol. 1992 Jul-Aug;13(4):1257-9. AJNR Am J Neuroradiol. 1992. PMID: 1636547 Free PMC article.

9

Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis.

Barkhof F, Hommes OR, Scheltens P, Valk J. Barkhof F, et al. Neurology. 1991 Aug;41(8):1219-22. doi: 10.1212/wnl.41.8.1219. Neurology. 1991. PMID: 1866009

10

Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images.

van Walderveen MA, Barkhof F, Hommes OR, Polman CH, Tobi H, Frequin ST, Valk J. van Walderveen MA, et al. Among authors: barkhof f. Neurology. 1995 Sep;45(9):1684-90. doi: 10.1212/wnl.45.9.1684. Neurology. 1995. PMID: 7675227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,516 results

Search Page

Filters